Mast cells promote homeostasis by limiting endothelin-1-induced toxicity

Nature

Volumn 432, Issue 7016, 2004, Pages 512-516

  Maurer, Marcus ^a,b,c   Wedemeyer, Jochen ^a,d,e   Metz, Martin ^a,b,d   Piliponsky, Adrian M ^d   Weller, Karsten ^b   Chatterjea, Devavani ^d   Clouthier, David E ^f   Yanagisawa, Masashi M ^g,h   Tsai, Mindy ^a,d   Galli, Stephen J ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF LOUISVILLE   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BACTERIA; PATHOLOGY; PHYSIOLOGY; PROTEINS; TOXICITY;

HOMEOSTASIS; MAST-CELL ACTIVATION; SEPSIS; VASOCONSTRICTOR ACTIVITY;

CELLS;

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR;

HOMEOSTASIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CELL ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; HOMEOSTASIS; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SEPSIS; VASOCONSTRICTION;

ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CELL DEGRANULATION; CELL SURVIVAL; CHYMASES; DIARRHEA; DRUG TOXICITY; EGTAZIC ACID; ENDOTHELIN-1; FEMALE; HOMEOSTASIS; INJECTIONS, INTRAPERITONEAL; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PERITONITIS; PROTO-ONCOGENE PROTEINS C-KIT; SERINE ENDOPEPTIDASES; STEM CELLS; SURVIVAL RATE;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 9644269070     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03085     Document Type: Article

References (30)

1. Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415 (1988).
2. Wanecek, M., Weitzberg, E., Rudehill, A. & Oldner, A. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol. 407, 1-15 (2000).
3. Kedzierski, R. M. & Yanagisawa, M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41, 851-876 (2001).
4. Szalay, L., Kaszaki, J., Nagy, S. & Boros, M. The role of endothelin-1 in circulatory changes during Hypodynamic sepsis in the rat. Shock 10, 123-128 (1998).
5. Oman, D. A., Chaudry, I. H. & Wang, P. The dissociation between upregulated endothelins and hemodynamic responses during polymicrobial sepsis. Biochim. Biophys. Acta 1501, 211-218 (2000).
6. Kawakami, T. & Galli, S. J. Regulation of mast-cell and basophil function and survival by IgE. Nature Rev. Immunol 2, 773-786 (2002).
7. Benoist, C. & Mathis, D. Mast cells in autoimmune disease. Nature 420, 875-878 (2002),
8. Echtenacher, B., Marmel, D, N. & Hültner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77 (1996).
9. Malaviya, R., Ikeda, T., Ross, E., & Abraham, S. N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 391, 77-80 (1996).
10. Galli, S. I., Chatterjea, D. & Tsai, M. in The Innate Immune Response to Infection (ed. Gordon, S.) 111-132 (ASM, Berlin, 2004).
11. Ehrenreich, H. et al. Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol. 4, 147-156 (1992).
12. Yamamura, H., Nabe, T., Kohno, S. & Ohata, K. Endothelin-1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur. J. Pharmacol. 265, 9-15 (1994).
13. Yamamura, H., Nabe, T., Kohno, S. & Ohata, K. Mechanism of histamine release by endothelin-1 distinct from that by antigen in mouse bone marrow-derived mast cells. Eur. J. Pharmacol 288, 269-275 (1995).
14. Metsärinne, K. P. et al. Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted peptide. Arterioscler. Thromb. Vasc. Biol 22, 268-273 (2002).
15. V mice and their increase by bone marrow transplantation. Blood 52, 447-452 (1978).
16. Gaili, S. J., Zsebo, K. M. & Geissler, E. N. The kit ligand, stem cell factor. Adv. Immunol. 55, 1-96 (1994).
17. Tsai, M., Tam, S. Y., Wedemeyer, J. & Galli, S. J. Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in viito and in vivo. Int. J. Hematol. 75, 345-349 (2002).
18. V mice. Evidence that cultured mast cells can give rise to both connective tissue and mucosal mast cells. J. Exp. Med. 162, 1025-1043 (1985).
19. Maurer, M. et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188, 2343-2348 (1998).
20. Boesiger, J. et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression. J. Exp. Med. 188, 1135-1145 (1998).
21. 1-31), in human mammary and coronary arteries in vitro. Br. J. Pharmacol. 134, 1360-1366 (2001).
22. Opgenorth, T. J. Endothelin receptor antagonism. Adv. Pharmacol 33, 1-64 (1995).
23. Clouthier, D. E., Williams, S. C., Hammer, R. E., Richardson, J. A. & Yanagisawa, M. Cell-autonomous and nonautonomous actions of endothelin-A receptor signaling in craniofacial and cardiovascular development. Dev. Biol 261, 506-519 (2003).
24. Tsai, M. et al. In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc. Natl Acad. Sci. USA 97, 9186-9190 (2000).
25. Prodeus, A. P., Zhou, X., Maurer, M., Galli, S. J. & Carroll, M. C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390, 172-175 (1997).
26. Ahn, G. Y. et al. The expression of endothelin-1 and its binding sites in mouse skin increased after ultraviolet B irradiation or local injection of tumor necrosis factor alpha. J. Dermatol 25, 78-84 (1998).
27. Sugiura, M., Inagami, T. & Kon, V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161, 1220-1227 (1989).
28. Lundblad, R. & Giercksky, K. E. Endothelin concentrations in experimental sepsis: profiles of big endothelin and endothelin 1-21 in lethal peritonitis in rats. Eur. J, Surg. 161, 9-16 (1995).
29. Boros, M., Szalay, L. & Kaszaki, J. Endothelin-1 induces mucosal mast cell degranulation and tissue injury via ETA receptors. Clin. Sci. (Lond.) 103 (suppl. 48), 31S-34S (2002).
30. Higginbotham, R. D. Mast cells and local resistance to Russell's viper venom. J. Immunol. 95, 867-875 (1965).